BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32182548)

  • 1. Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.
    Fan D; Kang JJ; Fan M; Wang H; Lee A; Yu Y; Chen L; Jillian Tsai C; McBride SM; Riaz N; Gelblum DY; Neal BP; Fetten J; Dunn LA; Michel LS; Boyle JO; Cohen MA; Roman BR; Ganly I; Singh B; Wong RJ; Sherman EJ; Lee NY
    Oral Oncol; 2020 May; 104():104641. PubMed ID: 32182548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot.
    Lee A; Kang JJ; Bernstein H; Marqueen KE; Neal B; Kelly CM; Dickson MA; Jillian Tsai C; Tap W; Singer S; Alektiar K; Lee NY
    Cancer Med; 2021 Jul; 10(13):4221-4227. PubMed ID: 34085781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofractionated palliative volumetric modulated arc radiotherapy with the Radiation Oncology Study Group 8502 "QUAD shot" regimen for incurable head and neck cancer.
    Toya R; Saito T; Yamaguchi K; Matsuyama T; Watakabe T; Matsumoto T; Yoshida R; Hirosue A; Murakami D; Orita Y; Nakayama H; Oya N
    Radiat Oncol; 2020 May; 15(1):123. PubMed ID: 32460865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative Quad Shot Radiation Therapy with or without Concurrent Immune Checkpoint Inhibition for Head and Neck Cancer.
    Upadhyay R; Gogineni E; Tocaj G; Ma SJ; Bonomi M; Bhateja P; Konieczkowski DJ; Baliga S; Mitchell DL; Jhawar SR; Zhu S; Grecula JC; Dibs K; Gamez ME; Blakaj DM
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy Oncology Group 8502 "QUAD shot" regimen using volumetric modulated arc therapy for incurable head and neck cancer.
    Toya R; Fukugawa Y; Saito T; Matsuyama T; Yoshida R; Murakami D; Orita Y; Nakayama H; Oya N
    Oral Oncol; 2024 Apr; 151():106752. PubMed ID: 38518555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot.
    Ma J; Lok BH; Zong J; Gutiontov SI; Cai X; Bell AC; Shcherba M; Xiao H; Sherman EJ; Tsai CJ; Riaz N; McBride SM; Cahlon O; Lee NY
    Int J Part Ther; 2018; 4(4):10-19. PubMed ID: 30246055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers.
    Lok BH; Jiang G; Gutiontov S; Lanning RM; Sridhara S; Sherman EJ; Tsai CJ; McBride SM; Riaz N; Lee NY
    Oral Oncol; 2015 Oct; 51(10):957-62. PubMed ID: 26282714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclical hypofractionated radiotherapy technique for palliative treatment of locally advanced head and neck cancer: institutional experience and review of palliative regimens.
    Finnegan TS; Bhatt NH; Shaughnessy JN; Perez C; Redman R; Silverman C; Bumpous J; Potts K; Dunlap NE
    J Community Support Oncol; 2016 Jan; 14(1):29-36. PubMed ID: 26870840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
    Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
    JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.
    Phan J; Sio TT; Nguyen TP; Takiar V; Gunn GB; Garden AS; Rosenthal DI; Fuller CD; Morrison WH; Beadle B; Ma D; Zafereo ME; Hutcheson KA; Kupferman ME; William WN; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):30-41. PubMed ID: 27325480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.
    Corry J; Peters LJ; Costa ID; Milner AD; Fawns H; Rischin D; Porceddu S
    Radiother Oncol; 2005 Nov; 77(2):137-42. PubMed ID: 16260054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
    De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
    J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
    Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation of pelvic and head and neck cancer with paclitaxel and a novel radiotherapy regimen.
    Carrascosa LA; Yashar CM; Paris KJ; Larocca RV; Faught SR; Spanos WJ
    J Palliat Med; 2007 Aug; 10(4):877-81. PubMed ID: 17803408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional Fractionation versus Quad Shot in Advanced Head-and-Neck Cancers: A Randomized Controlled Trial.
    Choudhary A; Gupta A
    Indian J Palliat Care; 2019; 25(4):527-534. PubMed ID: 31673207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
    Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.
    Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1299-304. PubMed ID: 11728690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
    Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.